164 related articles for article (PubMed ID: 24935337)
21. The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice.
Perkins DL; Michaelson J; Marshak-Rothstein A
J Immunol; 1987 Jan; 138(2):466-9. PubMed ID: 2878956
[TBL] [Abstract][Full Text] [Related]
22. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
Masuda S; Ageyama N; Shibata H; Obara Y; Ikeda T; Takeuchi K; Ueda Y; Ozawa K; Hanazono Y
Exp Hematol; 2009 Oct; 37(10):1250-1257.e1. PubMed ID: 19638293
[TBL] [Abstract][Full Text] [Related]
23. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
[TBL] [Abstract][Full Text] [Related]
24. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
[TBL] [Abstract][Full Text] [Related]
25. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.
Liu F; Chen H; Chen T; Lau CS; Yu FX; Chen K; Chen HP; Pan RS; Chan GC; Zhang XY; Nie YJ
Lupus; 2020 Jul; 29(8):872-883. PubMed ID: 32580680
[TBL] [Abstract][Full Text] [Related]
27. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
28. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
Chun W; Tian J; Zhang Y
Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
[TBL] [Abstract][Full Text] [Related]
29. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.
Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON
Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.
Yang X; Yang J; Li X; Ma W; Zou H
Lupus; 2018 Jan; 27(1):49-59. PubMed ID: 28537524
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell transplantation inhibits abnormal activation of Akt/GSK3β signaling pathway in T cells from systemic lupus erythematosus mice.
Ji S; Guo Q; Han Y; Tan G; Luo Y; Zeng F
Cell Physiol Biochem; 2012; 29(5-6):705-12. PubMed ID: 22613971
[TBL] [Abstract][Full Text] [Related]
32. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
Zhang H; Zeng X; Sun L
Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
[TBL] [Abstract][Full Text] [Related]
33. Targeting of Deciduous Tooth Pulp Stem Cell-Derived Extracellular Vesicles on Telomerase-Mediated Stem Cell Niche and Immune Regulation in Systemic Lupus Erythematosus.
Sonoda S; Murata S; Kato H; Zakaria F; Kyumoto-Nakamura Y; Uehara N; Yamaza H; Kukita T; Yamaza T
J Immunol; 2021 Jun; 206(12):3053-3063. PubMed ID: 34078710
[TBL] [Abstract][Full Text] [Related]
34. Immune therapeutic potential of stem cells from human supernumerary teeth.
Makino Y; Yamaza H; Akiyama K; Ma L; Hoshino Y; Nonaka K; Terada Y; Kukita T; Shi S; Yamaza T
J Dent Res; 2013 Jul; 92(7):609-15. PubMed ID: 23697344
[TBL] [Abstract][Full Text] [Related]
35. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
37. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
38. A new bone marrow transplantation method for stem cell disorders.
Ikehara S
Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
[TBL] [Abstract][Full Text] [Related]
39. hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages.
Guo F; Pan Q; Chen T; Liao S; Li S; Li A; Chen S; Chen J; Xiao Z; Su H; Yang L; Yang C; Liu HF; Pan Q
Stem Cell Res Ther; 2023 Aug; 14(1):211. PubMed ID: 37605271
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment
Ma W; Che J; Chen W; Wang D; Zhang H; Zhao Y
ACS Nano; 2024 May; 18(20):13249-13265. PubMed ID: 38720584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
